The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Reedy Lagoon Corporation (RLC) raises just over 12 per cent of what it had hoped through its pro-rata non-renounceable rights offer
  • The company offered over 78 million shares to investors in the hopes of raising $3.3 million but received applications for just over nine million, raising $362,787
  • Despite missing its target, RLC says it has sufficient funds to maintain its US-based lithium brine projects at Cayton Valley and Alkali Lake North
  • With $700,000 cash in the bank following this raise and no debt, Reedy also assures investors it is funded to continue securing new lithium projects
  • Company shares slumped 8 per cent to trade at 2.3 cents at 1:59 pm AEST

Reedy Lagoon Corporation (RLC) has raised just over 12 per cent of what it had hoped in its pro-rata non-renounceable rights offer.

At the start of May, the company told investors it would be launching an offer to raise $3.3 million under which participants could receive one new share for every seven held, at four cents each.

The offer closing date was extended to May 27, and, with the new shares issued today, the company revealed that of the 78 million shares on offer, shareholders had subscribed for just over nine million, raising $362,787.

This leaves over 69 million shares available for shortfall, which the directors of Reedy Lagoon can place at their discretion at the same price as the rights offer.

Despite missing the $3.3 million mark, the company said it had sufficient funds to maintain its US-based lithium brine projects at Cayton Valley and Alkali Lake North.

With $700,000 cash in the bank following this raise and no debt, Reedy also assured investors it is funded to continue securing new lithium projects.

Company shares were down 8 per cent and trading at 2.3 cents at 1:59 pm AEST.

RLC by the numbers
More From The Market Online
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after
Market Close Graphic

ASX Market Close: Bourse defies red futures to end up on 2025’s first trading day | Jan 2, 2024

The local bourse has defied morning predictions to end 34 points up, at 8,189 (a 0.44% gain) after ASX 200 futures originally suggested...